This review of radioactive iodide treatment (RAIT) extends from historical origins to its
modern utilization in differentiated thyroid cancer (DTC). The principles embedded in the …

Differentiated thyroid cancer (DTC) is the most common endocrine malignancy with a
growing incidence worldwide. The initial conventional management is surgery, followed by …

Purpose The purpose of the following commentary is to discuss recent controversies in the
use of radioactive iodine for differentiated thyroid cancer (DTC). Methods RM Tuttle (Thyroid …

Radioiodine is important in the diagnostic and therapeutic armamentarium of differentiated
thyroid cancer (DTC); however, many controversies persist. This article addresses some of …

Objective Identify and appraise clinical practice guidelines (CPGs) for radioactive iodine
(RAI) indications in differentiated thyroid carcinoma (DTC), and the treatment for radioactive …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

Background: Thyroid cancer is the most common endocrine malignancy, with differentiated
thyroid cancer (DTC) comprising∼ 93% of all thyroid cancers. While most cases of DTC are …

Differentiated thyroid cancers are typically iodine-avid and can be effectively treated with
radioiodine. In most patients, radioiodine treatment is done for ablation of residual tissue …

Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …